Breaking News, Collaborations & Alliances

Orasi, Biogen Enter Biomarker Technology Pact

Orasi Medical has entered into an agreement with Biogen Idec to test novel biomarkers for the development of treatments for central nervous system (CNS) disorders.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Orasi Medical has entered into an agreement with Biogen Idec to test novel biomarkers for the development of treatments for central nervous system (CNS) disorders. The companies will use Orasi’s technology to identify and test biomarkers based on magnetoencephalography (MEG) to assess the integrity of brain communication networks in real time and measure brain function in patients. “We are quite pleased to partner with Biogen Idec on this innovative project,” said Sarah Haecker, P...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters